Akari Therapeutics Plc
AKTX
Revenue
0.00
0.000.00%
-Assets
2.77M
▼-5.24M▼-65.41%
9 Months ChangeLiabilities
5.23M
▲2.19M▲71.79%
12 Months ChangeFree Cash Flow
-7.48M
▼-5.49M▼-276.30%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-04
Form 8-K
ID: 0000950170-24-112930
2024-09-18
Form 8-K
ID: 0000950170-24-107824
2024-09-06
Form 8-K
ID: 0000950170-24-104428
2024-08-19
Form 10-Q
ID: 0000950170-24-098576
2024-08-19
Form 8-K
ID: 0000950170-24-098535
2024-07-01
Form 8-K
ID: 0000950170-24-079669
2024-06-05
Form 8-K
ID: 0000950170-24-069414
2024-06-04
Form 8-K
ID: 0000950170-24-068304
2024-05-16
Form 8-K
ID: 0000950170-24-060806
2024-05-15
Form 10-Q
ID: 0000950170-24-060556